Nonalcoholic Fatty Liver Disease

Greater Awareness of NAFLD, NASH in Diabetes Needed

Greater Awareness of NAFLD, NASH in Diabetes Needed

By

Clinicians must be aware of the overlap between nonalcoholic fatty liver disease and nonalcoholic steatohepatitis and other metabolic disorders.

Saroglitazar May Help Treat Nonalcoholic Fatty Liver Disease

Saroglitazar May Help Treat Nonalcoholic Fatty Liver Disease

By

Treatment with saroglitazar was linked to sonographic improvement in fatty liver.

Metabolic Profile Worse in Type 2 Diabetes Patients With NAFLD

Metabolic Profile Worse in Type 2 Diabetes Patients With NAFLD

For obese patients with type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) is associated with an unfavorable metabolic profile.

Endocrine-Disrupting Chemicals May Cause Fatty Liver

Endocrine-Disrupting Chemicals May Cause Fatty Liver

By

Exposure to low doses of hormone-disrupting chemicals may alter the liver genome and function, thereby increasing susceptibility to obesity.

Fatty Liver Disease May Be Less Common in Type 1 Diabetes

Fatty Liver Disease May Be Less Common in Type 1 Diabetes

Patients with type 1 diabetes may be less likely to develop fatty liver disease.

Sign Up for Free e-Newsletters



CME Focus